Newsfeed
- Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units November 20, 2021Background: Aminoglycosides are the most prescribed antibiotics in neonatal intensive care units (NICU). Reducing exposure to antibiotics ...-label. In the near future, new methods based on micro sampling non-invasive samples should overcome actual difficulties for aminoglycosides
- Blood Proteome Profiling Of COVID-19 Patients Revealed Circulating Proteins MBL2, MMP3, IL2RA, FCGR2A, CCL5, GP1BA, VWF, ANG, SDC4 & CHL1 November 19, 2021A new study by researchers from the KTH Royal Institute of Technology-Sweden, Karolinska Institutet-Sweden and Karolinska University ...the first pandemic wave, the study team used a volumetric DBS home-sampling device to collect 878 samples from Stockholm, Sweden, randomly.
- Use of Quantitative Dried Blood Spots to Evaluate the Post-Vaccination Level of Neutralizing Antibodies against SARS-CoV-2 October 22, 2021To combat the COVID-19 pandemic, vaccines against SARS-CoV-2 are now given to protect populations worldwide. The level of neutralizing ...2.0 mm) for the finger prick and collected on a Capitainer qDBS 2 spot card (Capitainer AB, Stockholm, Sweden) following the manufacturer’s
- Opportunities for Improving Clinical Decisions with Patient Centric Remote Blood Sampling Approaches September 22, 2021This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the .../hemapen.Labcorp Pixel. https://www.pixel.labcorp.com/.Capitainer qDBS. https://capitainer.se/ (accessed 18 Aug 2021).HemaXis DB10. https://
- Self-Sampling Blood Collection And Storage Devices Market to Gain a Revenue Worth US$ 302.6 Mn by 2027 September 2, 2021According to the report, the global Self-Sampling Blood Collection And Storage Devices market was valued over US$ 90.25 Million in 2020 .It ...base, and region. Overview of Self-Sampling Blood Collection And Storage Devices Market Study Self-Sampling Blood Collection And Storage
Swedish Medtech start-up Capitainer raises SEK15 million to commercialise Capitainer qDBS dried blood spot sampling system
Capitainer AB, Linköping University and Karolinska University Hospital have been awarded 3M SEK
Patent on the novel Capitainer B product approved in the US
Capitainer-B – “effectively assist in eliminating the hematocrit-based area bias”